http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114480611-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2c32cbd6d7f9f78a85b4438f36eef39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c67a26a2289a3923f43e34e6934d765 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-30 |
| filingDate | 2021-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dbba0a3016f74fdef9c67feadd81c3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62e063946951c305e7fe110e5ae39d2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6521c8e6eb44a7461926e45d2b93fcf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87eddeae522b1d30f10938bdc3ac68c0 |
| publicationDate | 2022-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114480611-A |
| titleOfInvention | A method to distinguish diseased embryos from normal embryos with CNV microdeletion microduplication syndrome |
| abstract | The present invention relates to a method for identifying diseased embryos and normal embryos of CNV microdeletion and microduplication syndrome. The present invention belongs to the field of genetic diagnosis and human assisted reproduction, and more particularly, relates to preimplantation detection technology (PGT). According to the method of the present invention, the chromosomes of a patient with copy number variation (CNV) microdeletion-microduplication syndrome and their spouse, embryos after in vitro fertilization and a relative of the patient or fetal tissue with CNV microdeletion-microduplication syndrome are performed. Family haplotype linkage analysis can quickly, easily and accurately distinguish between embryos with CNV disease and normal embryos, and at the same time screen the embryos for chromosomal aneuploidy, improve the clinical pregnancy rate, and realize embryo transfer Early detection of diseased embryos, transfer of non-diseased embryos, prevention of the birth of defective children, and timely blocking of the genetic transmission of CNV microdeletion and microduplication syndrome disease to the next generation. To a certain extent, it has promoted the development and progress of human assisted reproductive technology. |
| priorityDate | 2021-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.